GINA STONE: Open Payments
NPI 1629675186 · GLENVIEW, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,214 in 64 payments from 15 companies in 2025. Trend: 2023 $114 · 2024 $951 · 2025 $2,214
Food & beverage: $1,959Consulting: $250Education: $5
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 8 | $457 |
| Medimetriks Pharmaceuticals, Inc. | 4 | $440 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 12 | $259 |
| PFIZER INC. | 7 | $230 |
| Galderma Laboratories, L.P. | 10 | $205 |
| ABBVIE INC. | 3 | $136 |
| Verrica Pharmaceuticals Inc. | 1 | $125 |
| Almirall LLC | 4 | $93 |
| MAYNE PHARMA COMMERCIAL LLC | 7 | $91 |
| GENZYME CORPORATION | 2 | $54 |
Products named: DUPIXENT, Genadur, CIBINQO, NEMLUVIO, Clindacin ETZ, ILUMYA, SKYRIZI, YCANTH.
Industry payments across IL — which companies pay providers there.
